| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |